{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:01:04Z","timestamp":1777953664316,"version":"3.51.4"},"reference-count":13,"publisher":"Informa UK Limited","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biopharmaceutical Statistics"],"DOI":"10.1080\/10543406.2026.2664711","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:14:22Z","timestamp":1777911262000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["A systematic analysis of the inherent dose uncertainty in autologous CAR T-cell products"],"prefix":"10.1080","author":[{"given":"Sangwook","family":"Choi","sequence":"first","affiliation":[{"name":"Bristol Myers Squibb","place":["Seattle, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kedar","family":"Dave","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["Seattle, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03193-7"},{"key":"e_1_3_2_3_1","unstructured":"Christin B et al. 2024. Determining toxicity risk in CAR T-cell therapy. US patent 12 163 952 B2 filed Feb 27 2018 and issued Dec 10 2024."},{"key":"e_1_3_2_4_1","volume-title":"Quantifying uncertainty in analytical measurement","author":"Ellison SL","year":"2012","unstructured":"Ellison SL, Williams A. 2012. Quantifying uncertainty in analytical measurement. 3rd ed. EURACHEM\/CITAC Guide CG 4.","edition":"3"},{"issue":"2","key":"e_1_3_2_5_1","first-page":"49","article-title":"Uncertainty of measurement: a review of the rules for calculating uncertainty components through functional relationships","volume":"33","author":"Farrance I","year":"2012","unstructured":"Farrance I, Frenkel R. 2012. Uncertainty of measurement: a review of the rules for calculating uncertainty components through functional relationships. Clin Biochem Rev. 33(2):49\u201375.","journal-title":"Clin Biochem Rev"},{"key":"e_1_3_2_6_1","volume-title":"Paper presented at Society for Immunotherapy of Cancer (SITC)","author":"Gilbert M","year":"2017","unstructured":"Gilbert M. 2017. Severe neurotoxicity in the phase 2 trial of JCAR015 in adult B-ALL (ROCKET study): analysis of patient, protocol and product attributes. Paper presented at Society for Immunotherapy of Cancer (SITC). Nov 8-12. National Harbor, MD."},{"key":"e_1_3_2_7_1","volume-title":"ISO 7886-1: sterile hypodermic syringes for single use \u2014 part 1: syringes for manual use","author":"International Organization for Standardization","year":"2017","unstructured":"International Organization for Standardization. 2017. ISO 7886-1: sterile hypodermic syringes for single use \u2014 part 1: syringes for manual use."},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01687-x"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-024-00652-3"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2001.094"},{"key":"e_1_3_2_11_1","unstructured":"Phillips P. 2016. Syringe accuracy (TOGC) estimates for ISO 7886-1 1 5 &10 mL. [accessed 2016 Oct]. https:\/\/stayconnected.org\/wp-content\/uploads\/2022\/08\/Calculating-ISO-7886-TOGC-1-5-10ml-1.pdf"},{"key":"e_1_3_2_12_1","volume-title":"Statistical tolerancing (Booklet No. 05). Bosch Group","author":"Robert Bosch GmbH","year":"2022","unstructured":"Robert Bosch GmbH. 2022. Statistical tolerancing (Booklet No. 05). Bosch Group, 3rd ed.","edition":"3"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005678"},{"key":"e_1_3_2_14_1","volume-title":"Considerations for the design of early-phase clinical trials of cellular and gene therapy products","author":"U.S. Food and Drug Administration","year":"2015","unstructured":"U.S. Food and Drug Administration. 2015. Considerations for the design of early-phase clinical trials of cellular and gene therapy products. Guidance for Industry. https:\/\/www.fda.gov\/media\/106369\/download"}],"container-title":["Journal of Biopharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10543406.2026.2664711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:14:24Z","timestamp":1777911264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10543406.2026.2664711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":13,"alternative-id":["10.1080\/10543406.2026.2664711"],"URL":"https:\/\/doi.org\/10.1080\/10543406.2026.2664711","relation":{},"ISSN":["1054-3406","1520-5711"],"issn-type":[{"value":"1054-3406","type":"print"},{"value":"1520-5711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}